Replies to post #313789 on Elite Pharmaceuticals Inc (ELTP)

[steve9465]

Well that would just be normal for elite. We never go up on news. Earnings is going to have to do it or never will.

[luvwetscent]

Allow me to reiterate...Isradipine just icing on the cake..trouble is there is no cake........Sungen products?..more pie in the sky dreaming by Hakimus.......let me think up some ice cream metaphors for percocet, norco, and the big one.."the folly"

[namtae]

Sure thing LOL

After reading all the gaga over Isradipine, that Elite is one of only 2 companies manufacturing it, but dont expect the alleged good news STEADY-III results to impact the share price

Translated: Getting shareholders ready for disappointment

Some may want others to believe everyone in the investment & medical community are ignorant and unable or too lazy to research who may benefit from an Isradipine approval for PD. Utter nonsense!!

The reason for this is to divert attention from the real concern. That being, an Isradipine approval for PD with a meaningful demand for the drug will cause many larger, more seasoned competitors to enter into the market and push Elite into oblivion

So the effort to buy Elite more time (the story of its public life) to generate financial results is the ploy here.. Hopefully the next new Elite BS story will be ready to be told by then

[DR Ryan]

Agree 100%. Even with fantastic trial results, it would take time for Elite to see in increase in revenue from Isradipine. We won't just wake up the next day and have a xxx% increase in revenue.

If the stock is flat on results day, that doesn't mean anything in the long run, or if it spikes up.

[The ELTP King]

You are correct in that Elite will not be mentioned in the speech at the conference.

However, you can be DAM sure if the results are THAT great they WILL be mentioned in MULTIPLE articles across the internet.

There is NO possibly way they won't be, given we are only one of two companies who produce the drug.

Again, if the results are THAT great.

When the results are announced, Elite will not be mentioned.

[jour_trader]

I agree on the stock price commentary here, but that is just one piece of the puzzle. If there is very positive news on Isradipine, the intrinsic value of the stock will increase giving leverage in other negotiations, regardless of how the stock price reacts. For the shareholders that are here until an acquisition, positive Isradipine news will benefit Elite and shareholders, near and long term through organic growth of sales & profits.